Takatsuki, Japan

Yuko Shinagawa

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Takatsuki, JP (2005 - 2007)
  • Osaka, JP (2007)

Company Filing History:


Years Active: 2005-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yuko Shinagawa: A Look at Her Patents and Career

Introduction: Yuko Shinagawa, an accomplished inventor based in Takatsuki, Japan, has made significant contributions to the field of pharmaceuticals. Holding four patents, her work primarily focuses on compounds that have therapeutic applications, particularly in treating osteoporosis. Her innovative approach has positioned her as a key figure in her industry.

Latest Patents: Among her latest inventions, Yuko has developed a series of calcium-sensing receptor (CaSR) antagonists. These compounds are represented by a specific formula, wherein each symbol is defined in her detailed specifications. The focus of these patents is on compounds that exhibit antagonistic actions toward the calcium-sensing receptor. Furthermore, her pharmaceutical compositions include calcium receptor antagonists and therapeutic drugs specifically aimed at combating osteoporosis.

Career Highlights: Yuko Shinagawa's career at Japan Tobacco Inc. highlights her dedication to research and innovation in the pharmaceutical sector. Her role has allowed her to explore and develop novel compounds that contribute to significant medical advancements. The impact of her work extends beyond patents, influencing the pharmaceutical landscape in meaningful ways.

Collaborations: Throughout her career, Yuko has collaborated with notable colleagues such as Takashi Nakagawa and Teruhiko Inoue. These professional relationships have fostered an environment of creativity and innovation, enabling her to push the boundaries of her research and develop effective therapeutic solutions.

Conclusion: Yuko Shinagawa's work exemplifies the spirit of innovation in the field of pharmaceuticals. With her patents focusing on calcium-sensing receptor antagonists and their applications in osteoporosis treatment, she continues to be a pioneering force. As her career unfolds, the medical community and patients alike will undoubtedly benefit from her ongoing contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…